x

Coronavirus

Sri Lanka to Receive 600,000 Doses of Sinopharm Vaccine from China

COLOMBO, Sri Lanka — Sri Lanka said on Tuesday that it will receive a donation of 600,000 doses of Sinopharm vaccine from China this week.

Authorities say the vaccine will first be given to Chinese citizens in Sri Lanka. There are several thousand Chinese working at various projects in the country.

Government spokesman Ramesh Pathirana said the vaccine will be given to Sri Lankans once the country receives a clearance from the World Health Organization.

He said WHO has not yet recommended the universal use of Sinopharm.

Sri Lanka has so far received 1,264,000 doses of the Oxford-AstraZeneca vaccine and has inoculated 903,467 people.

It has approved three vaccines: Oxford-AstraZeneca, Russia's Sputnik V and China’s Sinopharm.

Sri Lanka has decided to buy 7 million doses of Sputnik V.

RELATED

BEIJING (AP) — The hunt for the origins of COVID-19 has gone dark in China, the victim of political infighting after a series of stalled and thwarted attempts to find the source of the virus that killed millions and paralyzed the world for months.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Over 100 Pilot Whales Beached on Western Australian Coast Have Been Rescued, Officials Say

MELBOURNE, Australia (AP) — More than 100 long-finned pilot whales that beached on the western Australian coast Thursday have returned to sea, while 29 died on the shore, officials said.

On Monday, April 22, 2024, history was being written in a Manhattan courtroom.

PARIS - With heavy security set for the 2024 Paris Olympic Games during a time of terrorism, France has asked to use a Greek air defense system as well although talks are said to have been going on for months.

WASHINGTON (AP) — A tiny Philip Morris product called Zyn has been making big headlines, sparking debate about whether new nicotine-based alternatives intended for adults may be catching on with underage teens and adolescents.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.